Activation of MMP-2 in response to vascular injury is mediated by phosphatidylinositol 3-kinase-dependent expression of MT1-MMP

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 6 56-6, 2004, Pages

  Zahradka, Peter ^a,b   Harding, Greg ^a,b   Litchie, Brenda ^b   Thomas, Shawn ^b   Werner, Jeffrey P ^a,b   Wilson, David P ^a,b   Yurkova, Natalia ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

Furin; LY 294002; Matrix metalloproteinase; Restenosis; Wortmannin

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; FURIN; GELATINASE A; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; WORTMANNIN;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; INTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RESTENOSIS; WESTERN BLOTTING; ZYMOGRAPHY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CELL MOVEMENT; CHROMONES; CORONARY VESSELS; ENZYME INHIBITORS; HYPERPLASIA; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MORPHOLINES; MUSCLE, SMOOTH, VASCULAR; ORGAN CULTURE TECHNIQUES; PHOSPHODIESTERASE INHIBITORS; SWINE; TUNICA INTIMA;

EID: 9344247498     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00230.2004     Document Type: Article

References (68)

1. Angliker H, Wikstrom P, Shaw E, Brenner C, and Fuller RS. The synthesis of inhibitors for processing proteinases and their action on the Kex2 proteinase of yeast. Biochem J 293: 75-81, 1993.
2. Bendeck MP, Zempo N, Clowes AW, Galardy RE, and Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 75: 539-545, 1994.
3. Bond M, Chase AJ, Baker AH, and Newby AC. Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res 50: 556-565, 2001.
4. Bornfeldt KE, Raines EW, Graves LM, Skinner MP, Krebs EG, and Ross R. Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation. Ann NY Acad Sci 766: 416-430, 1995.
5. Carpenter CL and Cantley LC. Phosphoinositide 3-kinase and the regulation of cell growth. Biochim Biophys Acta 1288: M11-M16, 1996.
6. Danilkovitch A, Skeel A, and Leonard EJ. Macrophage stimulating protein-induced epithelial cell adhesion is mediated by a PI3-K-dependent, but FAK-independent mechanism. Exp Cell Res 248: 575-582, 1999.
7. Davies SP, Reddy H, Caivano M, and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105, 2000.
8. De Kleijn DP, Sluijter JP, Smit J, Velema E, Richard W, Schoneveld AH, Pasterkamp G, and Borst C. Furin and membrane type-1 metalloproteinase mRNA levels and activation of metalloproteinase-2 are associated with arterial remodeling. FEBS Lett 501: 37-41, 2001.
9. Ellerbroek SM, Halbleib JM, Benavidez M, Warmka JK, Wattenberg EV, Stack MS, and Hudson LG. Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association. Cancer Res 61: 1855-1861, 2001.
10. Foda HD, George S, Rollo E, Drews M, Conner C, Cao J, Panettieri RA Jr, and Zucker S. Regulation of gelatinases in human airway smooth muscle cells: mechanism of progelatinase A activation. Am J Physiol Lung Cell Mol Physiol 277: L174-L182, 1999.
11. Forough R, Koyama N, Hasenstab D, Lea H, Clowes M, Nikkari ST, and Clowes AW. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. Circ Res 79: 812-820, 1996.
12. Geimer P and Bade EG. The epidermal growth factor-induced migration of rat liver epithelial cells is associated with a transient inhibition of DNA synthesis. J Cell Sci 100: 349-355, 1991.
13. George SJ, Baker AH, Angelini GD, and Newby AC. Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins. Gene Ther 5: 1552-1560, 1998.
14. Goncharova EA, Ammit AJ, Irani C, Carroll RG, Eszterhas AJ, Panettieri RA, and Krymskaya VP. PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 283: L354-L363, 2002.
15. Groves PH, Banning AP, Penny WJ, Lewis MJ, Cheadle HA, and Newby AC. Kinetics of smooth muscle cell proliferation and intimal thickening in a pig carotid model of balloon injury. Atherosclerosis 117: 83-96, 1995.
16. Hemmings BA. PH domains - a universal membrane adapter. Science 275: 1899, 1997.
17. Hess AR, Seftor EA, Seftor RE, and Hendrix MJ. Phosphoinositide 3-kinase regulates membrane type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res 63: 4757-4762, 2003.
18. Huang J and Kontos CD. Inhibition of vascular smooth muscle cell proliferation, migration, and survival by the tumor suppressor protein PTEN. Arterioscler Thromb Vasc Biol 22: 745-751, 2002.
19. Imai Y and Clemmons DR. Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-1. Endocrinology 140: 4228-4235, 1999.
20. Kanaki T, Bujo H, Mori S, Yanjuan Z, Takahashi K, Yokote K, Morisaki N, and Saito Y. Functional analysis of aortic endothelial cells expressing mutant PDGF receptors with respect to expression of matrix metalloproteinase-3. Biochem Biophys Res Commun 294: 231-237, 2002.
21. Kapeller R, Toker A, Cantley LC, and Carpenter CL. Phosphoinositide 3-kinase binds constitutively to alpha/beta-tubulin and binds to gamma-tubulin in response to insulin. J Biol Chem 270: 25985-25991, 1995.
22. Kenagy RD, Hart CE, Stetler-Stevenson WG, and Clowes AW. Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9. Circulation 96: 3555-3560, 1997.
23. Kinashi T, Escobedo JA, Williams LT, Takatsu K, and Springer TA. Receptor tyrosine kinase stimulates cell-matrix adhesion by phosphatidylinositol 3 kinase and phospholipase C-gamma 1 pathways. Blood 86: 2086-2090, 1995.
24. Kubiatowski T, Jang T, Lachyankar MB, Salmonsen R, Nabi RR, Quesenberry PJ, Litofsky NS, Ross AH, and Recht LD. Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas. J Neurosurg 95: 480-488, 2001.
25. Kundra V, Escobedo JA, Kazlauskas A, Kim HK, Rhee SG, Williams LT, and Zetter BR. Regulation of chemotaxis by the platelet-derived growth factor receptor-beta. Nature 367: 474-476, 1994.
26. Kusch A, Tkachuk S, Haller H, Dietz R, Gulba DC, Lipp M, and Dumler I. Urokinase stimulates human vascular smooth muscle cell migration via a phosphatidylinositol 3-kinase-Tyk2 interaction. J Biol Chem 275: 39466-39473, 2000.
27. Kuzuya M, Kanda S, Sasaki T, Tamaya-Mori N, Cheng XW, Itoh T, Itohara S, and Iguchi A. Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia. Circulation 108: 1375-1381, 2003.
28. Larson DE, Zahradka P, and Sells BH. Control points in eucaryotic ribosome biogenesis. Biochem Cell Biol 69: 5-22, 1991.
29. Li C, Cantor WJ, Nili N, Robinson R, Fenkell L, Tran YL, Whittingham HA, Tsui W, Cheema AN, Sparkes JD, Pritzker K, Levy DE, and Strauss BH. Arterial repair after stenting and the effects of GM6001, a matrix metalloproteinase inhibitor. J Am Coll Cardiol 39: 1852-1858, 2002.
30. Lijnen HR, Soloway P, and Collen D. Tissue inhibitor of matrix metalloproteinases-1 impairs arterial neointima formation after vascular injury in mice. Circ Res 85: 1186-1191, 1999.
31. Lymn JS, Gallagher KL, Clunn GF, Fexby SE, Patel MK, and Hughes AD. PDGF stimulates DNA synthesis in human vascular smooth muscle cells via a novel wortmannin-insensitive phosphatidylinositol 3-kinase. FEBS Lett 555: 591-596, 2003.
32. Maquoi E, Noel A, Frankenne F, Angliker H, Murphy G, and Foidart JM. Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor. FEBS Lett 424: 262-266, 1998.
33. Mignatti P and Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73: 161-195, 1993.
34. Moon MC, Molnar K, Yau L, and Zahradka P. Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia following arterial injury. J Vasc Surg 40: 130-137, 2004.
35. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, and Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 272: 2446-2451, 1997.
36. Palumbo R, Gaetano C, Melillo G, Toschi E, Remuzzi A, and Capogrossi MC. Shear stress downregulation of platelet-derived growth factor receptor-beta and matrix metalloprotease-2 is associated with inhibition of smooth muscle cell invasion and migration. Circulation 102: 225-230, 2000.
37. Pauly RR, Passaniti A, Bilato C, Monticone R, Cheng L, Papadopoulos N, Gluzband YA, Smith L, Weinstein C, and Lakatta EG. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res 75: 41-54, 1994.
38. Prescott MF, Sawyer WK, Linden-Reed J, Jeune M, Chou M, Caplan SL, and Jeng AY. Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury. Ann NY Acad Sci 878: 179-190, 1999.
39. Rajavashisth TB, Xu XP, Jovinge S, Meisel S, Xu XO, Chai NN, Fishbein MC, Kaul S, Cercek B, Sharifi B, and Shah PK. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Circulation 99: 3103-3109, 1999.
40. Rankin S, Hooshmand-Rad R, Claesson-Welsh L, and Rozengurt E. Requirement for phosphatidylinositol 3′-kinase activity in platelet-derived growth factor-stimulated tyrosine phosphorylation of p 125 focal adhesion kinase and paxillin. J Biol Chem 271: 7829-7834, 1996.
41. Reiske HR, Kao SC, Cary LA, Guan JL, Lai JF, and Chen HC. Requirement of phosphatidylinositol 3-kinase in focal adhesion kinase-promoted cell migration. J Biol Chem 274: 12361-12366, 1999.
42. Rozen S and Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. In: Bioinformatics Methods and Protocols: Methods in Molecular Biology, edited by Krawetz S and Misener S. Totowa, NJ: Humana, 2000, p. 365-386.
43. Sato H, Kinoshita T, Takino T, Nakayama K, and Seiki M. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 393: 101-104, 1996.
44. Saward L and Zahradka P. Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ Res 81: 249-257, 1997.
45. Saward L and Zahradka P. Coronary artery smooth muscle in culture: migration of heterogeneous cell populations from vessel wall. Mol Cell Biochem 176: 53-59, 1997.
46. Seiki M. The cell surface: the stage for matrix metalloproteinase regulation of migration. Curr Opin Cell Biol 14: 624-632, 2002.
47. Shigematsu K, Koyama H, Olson NE, Cho A, and Reidy MA. Phosphatidylinositol 3-kinase signaling is important for smooth muscle cell replication after arterial injury. Arterioscler Thromb Vasc Biol 20: 2373-2378, 2000.
48. Shofuda K, Nagashima Y, Kawahara K, Yasumitsu H, Miki K, and Miyazaki K. Elevated expression of membrane-type 1 and 3 matrix metalloproteinases in rat vascular smooth muscle cells activated by arterial injury. Lab Invest 78: 915-923, 1998.
49. Southgate KM, Fisher M, Banning AP, Thurston VJ, Baker AH, Fabunmi RP, Groves PH, Davies M, and Newby AC. Upregulation of basement membrane-degrading metalloproteinase secretion after balloon injury of pig carotid arteries. Circ Res 79: 1177-1187, 1996.
50. Stawowy P, Blaschke F, Kilimnik A, Goetze S, Kallisch H, Chretien M, Marcinkiewicz M, Fleck E, and Graf K. Proprotein convertase PC5 regulation by PDGF-BB involves PI3-kinase/p70(s6)-kinase activation in vascular smooth muscle cells. Hypertension 39: 399-404, 2002.
51. Stawowy P, Marcinkiewicz J, Graf K, Seidah N, Chretien M, Fleck E, and Marcinkiewicz M. Selective expression of the proprotein convertases furin, pc5, and pc7 in proliferating vascular smooth muscle cells of the rat aorta in vitro. J Histochem Cytochem 49: 323-332, 2001.
52. Uhm JH, Dooley NP, Villemure JG, and Yong VW. Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C. Clin Exp Metastasis 14: 421-433, 1996.
53. Wang H and Keiser JA. Expression of membrane-type matrix metalloproteinase in rabbit neointimal tissue and its correlation with matrix-metalloproteinase-2 activation. J Vasc Res 35: 45-54, 1998.
54. Webb KE, Henney AM, Anglin S, Humphries SE, and McEwan JR. Expression of matrix metalloproteinases and their inhibitor TIMP-1 in the rat carotid artery after balloon injury. Arterioscler Thromb Vasc Biol 17: 1837-1844, 1997.
55. Wennstrom S, Hawkins P, Cooke F, Hara K, Yonezawa K, Kasuga M, Jackson T, Claesson-Welsh L, and Stephens L. Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Curr Biol 4: 385-393, 1994.
56. Willis AI, Fuse S, Wang XJ, Chen E, Tuszynski GP, Sumpio BE, and Gahtan V. Inhibition of phosphatidylinositol 3-kinase and protein kinase C attenuates extracellular matrix protein-induced vascular smooth muscle cell chemotaxis. J Vasc Surg 31: 1160-1167, 2000.
57. Wilson D, Massaeli H, Pierce GN, and Zahradka P. Native and minimally oxidized low density lipoprotein depress smooth muscle matrix metalloproteinase levels. Mol Cell Biochem 249: 141-149, 2003.
58. Wilson DP, Saward L, Zahradka P, and Cheung PK. Angiotensin II receptor antagonists prevent neointimal proliferation in a porcine coronary artery organ culture model. Cardiovasc Res 42: 761-772, 1999.
59. Wymann M and Arcaro A. Platelet-derived growth factor-induced phosphatidylinositol 3-kinase activation mediates actin rearrangements in fibroblasts. Biochem J 298: 517-520, 1994.
60. Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, and Okada Y. Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket. J Med Chem 41: 1209-1217, 1998.
61. Yang GY, Yao JS, Huey M, Hashimoto T, and Young WL. Participation of PI3K and ERK1/2 pathways are required for human brain vascular smooth muscle cell migration. Neurochem Int 44: 441-446, 2004.
62. Yau L, Elliot T, Lalonde C, and Zahradka P. Repression of phosphoenolpyruvate carboxykinase gene activity by insulin is blocked by 3-aminobenzamide but not by PD128763, a selective inhibitor of poly-(ADP-ribose) polymerase. Eur J Biochem 253: 91-100, 1998.
63. Yau L, Litchie B, Thomas S, Storie B, Yurkova N, and Zahradka P. Endogenous mono-ADP-ribosylation mediates smooth muscle cell proliferation and migration via protein kinase N-dependent induction of c-fos expression. Eur J Biochem 270: 101-110, 2003.
64. 2 activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/NF-kappa B pathway. J Biol Chem 111: 30271-30282, 2002.
65. Zahradka P. Inhibition of phosphatidylinositol 3-kinase isoforms blocks smooth muscle cell proliferation and prevents restenosis in vitro. Emerging Therapeutic Targets 2: 97-99, 1998.
66. Zahradka P, Werner JP, Buhay S, Litchie B, Helwer G, and Thomas S. NF-kappaB activation is essential for angiotensin II-dependent proliferation and migration of vascular smooth muscle cells. J Mol Cell Cardiol 34: 1609-1621, 2002.
67. Zempo N, Koyama N, Kenagy RD, Lea HJ, and Clowes AW. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol 16: 28-33, 1996.
68. Zhou Z, Apte SS, Soininen R, Cao R, Baaklini GY, Rauser RW, Wang J, Cao Y, and Tryggvason K. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci USA 97: 4052-4057, 2000.